In a new peer-reviewed paper published in the New England Journal of Medicine, scientists from the Massachusetts Medical Society identified over 200 cases of a “devastating” blood clot side effect linked to the AstraZeneca vaccine.
CNBC reported the following:
“All of those patients had been given their first dose of the Oxford-AstraZeneca shot, and went to hospital with symptoms between 5 and 48 days after their vaccination. The median time between patients receiving their vaccination and going to hospital was 14 days, the findings showed.
The overall mortality rate for VITT in the study was 22%.
Researchers also found that 41% of patients presenting with VITT had no diagnosed underlying health issues. Of those who reported a past or current illness, the study found that no conditions or medications were prevalent that “would be unexpected in the general population.'”
Here’s what the study said:
- “Against the backdrop of a successful vaccination program in the United Kingdom, VITT has emerged as a rare but devastating complication.”
- “We have found that it often affects young, otherwise healthy vaccine recipients and that it is associated with a high mortality.”
- “In our cohort, 85% of the patients were younger than 60 years of age, despite the predominance of (Oxford/AstraZeneca) vaccination in older adults.”
Here are some of our trending reports on vaccine side effects:
To get the latest on our vaccine reports, SUBSCRIBE below: